INTS vs PAYX
Intensity Therapeutics, Inc. Common stock (INTS) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
INTS currently screens at market cap $7.7M. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the INTS and PAYX stock pages for the full models.
Not investment advice.